Especially, intranasal delivery has been shown to be an efficient way of delivering rmOPN protein and peptides to the CNS after carefully evaluating their penetrance, spreading and persistence in the brain through intranasal administration [6], and rmOPN and T-OPN have been shown to provide efficient protection against ischemic brain injury in a mouse model of stroke [6]. The gene discussed is SPP1; the disease is stroke disorder.